International Journal of Clinical Obstetrics and Gynaecology · Mar 2026

Does Polycystic Ovary Syndrome Predispose to Premature Ovarian Insufficiency? A Comparative Study of Ovarian Reserve Markers in Reproductive-Age Women

By AV V

Background: Polycystic ovary syndrome and premature ovarian insufficiency represent opposite ends of reproductive dysfunction, yet their long-term relationship remains debated. Because anti-Müllerian hormone, antral follicle count, gonadotropins, and ovarian volume reflect ovarian reserve differently, direct comparison of these markers may help clarify whether women with PCOS already show a biochemical pattern suggestive of accelerated ovarian depletion. Methods: This comparative cross-sectional study included 100 reproductive-age women, 50 with PCOS and 50 controls. Age, body mass index, menstrual pattern, serum anti-Mullerian hormone, total antral follicle count, day 3 follicle-stimulating hormone, day 3 luteinizing hormone, and ovarian volume were analyzed. Between-group comparisons were performed using the independent t-test, Mann-Whitney U test, and Fisher exact test as appropriate. Results: Mean age was comparable between the PCOS and control groups (26.68 ± 4.39 vs 27.76 ± 4.35 years, p=0.220), whereas body mass index was higher in the PCOS group (28.38 ± 2.70 vs 22.97 ± 1.16 kg/m², p<0.001). Irregular cycles were recorded in 96.0% of women with PCOS and in none of the controls (p<0.001). Women with PCOS had significantly higher anti-Müllerian hormone levels (6.08 ± 1.67 vs 2.49 ± 0.80 ng/mL), higher antral follicle count (22.26 ± 6.38 vs 11.02 ± 2.61), higher day 3 luteinizing hormone (11.66 ± 2.36 vs 5.92 ± 0.69 mIU/mL), and larger ovarian volume [median 11.05 (10.43-12.38) vs 6.95 (6.40-7.47) cm³], while day 3 follicle-stimulating hormone was lower (5.61 ± 1.21 vs 7.02 ± 1.00 mIU/mL), all p<0.001. Conclusion: In this cohort, women with PCOS did not demonstrate a reserve profile suggestive of imminent ovarian insufficiency. Instead, they showed higher follicular reserve markers and lower basal FSH than controls. The findings argue against equating PCOS with early biochemical ovarian failure, although they do not settle whether the tempo of ovarian ageing later diverges across the life course.

doi.org/10.33545/gynae.2026.v10.i2j.2121Open accessBiomarkers

AgingResearch.News